Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Current Deferred Revenue (2022 - 2025)

Core Laboratories' Current Deferred Revenue history spans 4 years, with the latest figure at $5.6 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 40.51% year-over-year to $5.6 million; the TTM value through Dec 2025 reached $5.6 million, down 40.51%, while the annual FY2025 figure was $5.6 million, 40.51% down from the prior year.
  • Current Deferred Revenue reached $5.6 million in Q4 2025 per CLB's latest filing, down from $7.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $9.8 million in Q1 2025 to a low of $4.6 million in Q3 2023.
  • Average Current Deferred Revenue over 4 years is $6.6 million, with a median of $5.7 million recorded in 2022.
  • Peak YoY movement for Current Deferred Revenue: surged 96.26% in 2024, then crashed 40.51% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $5.9 million in 2022, then fell by 19.98% to $4.8 million in 2023, then soared by 96.26% to $9.3 million in 2024, then plummeted by 40.51% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Current Deferred Revenue are $5.6 million (Q4 2025), $7.3 million (Q3 2025), and $9.1 million (Q2 2025).